Phase III, Randomised, Double-Blind, Multicentre Study to Evaluate the Efficacy and Safety of Vonoprazan Compared With Lansoprazole in Asian Patients With Erosive Oesophagitis

Gut - United Kingdom
doi 10.1136/gutjnl-2019-318365
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Randomised Clinical Trial: Vonoprazan Versus Lansoprazole for the Initial Relief of Heartburn in Patients With Erosive Oesophagitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

OP0253 a Phase Iii Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept or Placebo on Standard of Care in Patients With Active Class Iii or Iv Lupus Nephritis

2018English

Efficacy and Safety of Velmanase Alfa in the Treatment of Patients With Alpha-Mannosidosis: Results From the Core and Extension Phase Analysis of a Phase III Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial

Journal of Inherited Metabolic Disease
Genetics
2018English

A Phase 2, Randomized, Double-Blind, Multicenter Trial to Evaluate the Safety and Efficacy of Three Dosing Regimens of Isavuconazole Compared With Fluconazole in Patients With Uncomplicated Esophageal Candidiasis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Efficacy and Safety of Subcutaneous Tabalumab, a Monoclonal Antibody to B-Cell Activating Factor, in Patients With Systemic Lupus Erythematosus: Results From ILLUMINATE-2, a 52-Week, Phase III, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2015English

A Phase III Randomized Study to Evaluate the Efficacy and Safety of CT-P13 Compared With Reference Infliximab in Patients With Active Rheumatoid Arthritis: 54-Week Results From the PLANETRA Study

Arthritis Research & Therapy
2016English

Efficacy and Safety of Analgesic Treatment for Depression in People With Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)

Drugs and Aging
GerontologyGeriatricsPharmacology
2018English

A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2008English

Efficacy of Antibiotic Treatment in Patients With Chronic Low Back Pain and Modic Changes (The AIM Study): Double Blind, Randomised, Placebo Controlled, Multicentre Trial

British Medical Journal
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy